Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 12/2007

Open Access 01-12-2007 | Letter to the Editor

Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA)

Authors: Saskia K. Klein, Bart J. Biemond, Marinus H. J. van Oers

Published in: Annals of Hematology | Issue 12/2007

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Tallman MS, Anderson JW, Schiffer CA et al (1997) All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337:1021–1028PubMedCrossRef
2.
Frankel SR, Eardley A, Lauwers G, et al (1992) The ‘retinoic acid syndrome’ in acute promyelocytic leukemia. Ann Int Med 117:292–301PubMed
3.
Fenaux P, Boutton de S (1998) Retinoic acid syndrome, recognition, prevention and management. Drug Saf 18(4):273–279PubMedCrossRef
4.
Avvisati G, Lo Coco F, Diverio D et al (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a gruppo Italiano Malattie Ematologiche maligne dell’ adulto (GIMEMA) pilot study. Blood 88:1390–1398PubMed
5.
De Botton S, Dombret H, Sanz M et al, European APL Group (1998) Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 92:2712–2718PubMed
6.
Fabbiano F, Magrin S, Cangialosi C, Felice R, Mirto S, Pitrolo F (2005) All-trans retinoic acid induced cardiac and skeletal myositis in induction therapy of acute promyelocytic leukaemia. Br J Haematol 129:442–445CrossRef
7.
Kakkar N, Dhameja N, Jasmina, Das A, Radotra BD, Varma S (2002) ATRA syndrome with extensive organ infiltration. Am J Hematol 71(1):62–64PubMedCrossRef
Metadata
Title
Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA)
Authors
Saskia K. Klein
Bart J. Biemond
Marinus H. J. van Oers
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0333-3

Other articles of this Issue 12/2007

Annals of Hematology 12/2007 Go to the issue

Original Article

Rituximab therapy for chonic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis

Letter to the Editor

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation

Original Article

Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi

Letter to the Editor

Rituximab in autoimmune pancytopenia: a case report and review of literature

Original Article

A multicenter analysis of the FIP1L1-αPDGFR fusion gene in Japanese idiopathic hypereosinophilic syndrome: an aberrant splicing skipping the αPDGFR exon 12

Letter to the Editor

Refractory multiple myeloma treated with homoharringtonine: report of two cases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits